Position paper: The time for cooperative group study of ropeginterferon alfa‐2b in young patients with myeloproliferative neoplasms is now
Year: 2023
Type: article
Source: Pediatric Blood & Cancer
DOI: 10.1002/pbc.30559
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4384466716
